Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type-2 Diabetes Mellitus (T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07609992
What this trial is testing

The Effect of OptiFibre Dietary Fiber on Carbohydrate Metabolism and Intestinal Microbiota Metabolism in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes (T2DM)
Pirogov Russian National Research Medical University 80
Testing effectiveness (Phase 2)Study completedNCT02330549
What this trial is testing

ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD

Who this might be right for
Prediabetic StateNon-alcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
Tobira Therapeutics, Inc. 45
Early research (Phase 1)Study completedNCT01129258
What this trial is testing

Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders
Pfizer 110
Not applicableUnknownNCT06191328
What this trial is testing

A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes
Yufan Wang 40
Testing effectiveness (Phase 2)Study completedNCT04515849
What this trial is testing

Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Diseases
AstraZeneca 248
Post-approval studies (Phase 4)Not Yet RecruitingNCT07636161
What this trial is testing

PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)

Who this might be right for
Type 2 DiabetesType 2 Diabetes (T2DM)
University of Miami 30
Not applicableStudy completedNCT07303127
What this trial is testing

Combination of Bitter Melon Extract and Snakehead Fish Powder to Reduce Glycaemia in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Universitas Muhammadiyah Surakarta 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT07055386
What this trial is testing

Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 90
Post-approval studies (Phase 4)Looking for participantsNCT06613854
What this trial is testing

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
University Medical Centre Ljubljana 90
Not applicableLooking for participantsNCT07656805
What this trial is testing

Anti-inflammatory Dietary Intervention in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Anhui Medical University 88
Not applicableLooking for participantsNCT07094529
What this trial is testing

Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study

Who this might be right for
Type 2 Diabetes (T2DM)Hypoglycemia (Diabetic)
Ottawa Hospital Research Institute 120
Very early researchEnrolling By InvitationNCT07209527
What this trial is testing

Truway Diagnostic Tools in Primary Care

Who this might be right for
Chronic DiseaseType 2 Diabetes Mellitus (T2DM), Obesity, OverweightHypertension+6 more
Truway Health, Inc. 200
Early research (Phase 1)Study completedNCT01396161
What this trial is testing

PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 64
Post-approval studies (Phase 4)UnknownNCT05331469
What this trial is testing

Difference of Basal Insulin Titration Method in Reducing HbA1c Among Type 2 Diabetes Mellitus (T2DM) Patients.

Who this might be right for
to Identify Which Titration Regimen of Basal Insulin (Being Daily Titration vs 3 Daily Titration) is Better in Reducing hba1c and Have Lesser Hypoglycemia
University of Malaya 70
Not applicableLooking for participantsNCT07355270
What this trial is testing

A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)

Who this might be right for
Type-2 Diabetes Mellitus
Aqua Medical, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT04141241
What this trial is testing

Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular

Who this might be right for
Type 2 Diabetes Mellitus With Circulatory Complciation
Bota Bio Co., Ltd. 82
Not applicableActive Not RecruitingNCT06588127
What this trial is testing

Health Behavior Nudge Strategies for Chronic Disease Patients: the Study of Hypertension and Type 2 Diabetes

Who this might be right for
Economics, BehavioralHypertensionType 2 Diabetes Mellitus (T2DM)+2 more
Lin Han 133
Large-scale testing (Phase 3)UnknownNCT05102149
What this trial is testing

Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd. 672
Not applicableStudy completedNCT07539584
What this trial is testing

Adiponectin in Patients With Metabolic Disorders

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Type 2 Diabetes Mellitus (T2DM)
Moscow Regional Research and Clinical Institute (MONIKI) 130
Post-approval studies (Phase 4)Study completedNCT00456352
What this trial is testing

Duodenal Exclusion for the Treatment of T2DM

Who this might be right for
Diabetes
Medtronic - MITG 37
Next Page